jRCT1080224940已完成3 期
An open-label, single-group, multi-center, Phase III study to evaluate the efficacy and safety of ST-HT when administered 3 times daily for 3 days to the patients with common cold
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 158
- 试验地点
- 1
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Multi-center, Open label, single-arm
- 主要目的
- Treatment Purpose
入排标准
- 年龄范围
- 15age old over 至 No limit（—）
- 性别
- All
入选标准
- •Common cold patient diagnosed by the invetigator
- •age: 15 years old and above at the time of giving consent
- •Patient who gives written consent
排除标准
- •Patinet who was diagnosed as influenza by the investigator
- •Patient with underlying chronic upper airway disease or lowe ariway disease
- •Patine with seasonal nasal allergy during taking the study medication
结局指标
主要结局
-
efficacy Overall improvement
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
2 期
STS Administration on Coronavirus Disease (COVID-19) Patients in Critical CareCOVID-19Virus DiseasesCorona Virus InfectionNCT05277285Hellenic Institute for the Study of Sepsis30
招募中
Unknown
Phase III randomized trial of HIPEC in Primary Stage three & Four Ovarian Cancer after Interval Cytoreductive Surgery (FOCUS)KCT0008399ational Cancer Center520
进行中（未招募）
1 期
Improvement of severe respiratory failure in Covid-19 patientsAssessment of clinical improvement of critically ill patients with confirmed Covid-19 by administering of sodium thiosulfateMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsEUCTR2022-000642-16-GRHellenic Institute for the Study of Sepsis30
进行中（未招募）
1 期
Phase I/II trial for vaccine therapy with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion in patients with metastatic malignant melanomaEUCTR2008-006253-41-NOThe Norwegian Radium Hospital, Oslo University Hospital25
进行中（未招募）
不适用
_Ovarian epithelial cancer : intraperitoneal resectable relapseMedDRA version: 17.1Level: PTClassification code 10033160Term: Ovarian epithelial cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-023035-42-ITICANCER